![](/img/cover-not-exists.png)
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
Saber, Haleh, Del Valle, Pedro, Ricks, Tiffany K., Leighton, John K.Language:
english
Journal:
Regulatory Toxicology and Pharmacology
DOI:
10.1016/j.yrtph.2017.09.001
Date:
September, 2017
File:
PDF, 598 KB
english, 2017